Ferragut, F. E. d. V., Cagnoni, A., Colombo, L. L., Sánchez Terrero, C., Wolfenstein Todel, C., Troncoso, M. F., . . . Elola, M. T. (2019). Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth. Web
Citación estilo ChicagoFerragut, Fatima Eneida del Valle, et al. Dual Knockdown of Galectin-8 and Its Glycosylated Ligand, the Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166), Synergistically Delays in Vivo Breast Cancer Growth. 2019.
Cita MLAFerragut, Fatima Eneida del Valle, et al. Dual Knockdown of Galectin-8 and Its Glycosylated Ligand, the Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166), Synergistically Delays in Vivo Breast Cancer Growth. 2019.